![]() |
|
|



* Laboratory of Nutritional Biochemistry, Division of Food Functionality, National Food Research Institute, 2-1-12 Kannondai, Tsukuba 305-8642, Japan and
Graduate School of Life and Environmental Sciences, University of Tsukuba, Tennodai 1-1-1, Tsukuba 305-8572, Japan
2 To whom correspondence should be addressed. E-mail: idetaka{at}nfri.affrc.go.jp.
| ABSTRACT |
|---|
|
|
|---|
KEY WORDS: phytol phytanic acid dietary fat fatty acid oxidation
Phytol (3,7,11,15-tetramethylhexadec-2-en-1-ol) is a branched-chain fatty alcohol; it is abundant in nature as a part of the chlorophyll molecule. After its release from chlorophyll, phytol is converted into phytanic acid (3,7,11,15-tetramethylhexadecanoic acid) in mammals (13). The breakdown of phytol to phytanic acid takes place as follows: first, alcohol dehydrogenase converts phytol into the aldehyde; second, the aldehyde is converted to phytenic acid by the action of fatty aldehyde dehydrogenase (aldehyde dehydrogenase family 3 member A2, ALDH3a2)3 (1). Phytenoic acid is activated, becoming phytenoyl-CoA, and the double bond in phytenoyl-CoA is reduced by the action of phytenoyl-CoA reductase (3) to yield phytanoyl-CoA. Phytanic acid undergoes
-oxidation to produce pristanic acid (2,6,10,14-tetramethylpentadecanoic acid) via the following steps (1,2). Phytanoyl-CoA is converted into 2-hydroxyphytanoyl-CoA by phytanoyl-CoA hydroxylase. The reaction, catalyzed by 2-hydroxyphytanoyl-CoA lyase, in turn converts 2-hydroxyphytanoyl-CoA into pristanal, which is metabolized to pristanic acid by ALDH3a2. Pristanic acid is activated, becoming pristanoyl-CoA, and is degraded by the peroxisomal ß-oxidation pathway.
The potential role of PPAR and RXR in regulating lipid metabolism was clearly shown (4,5). Upon the binding of the ligands to these nuclear receptors, heterodimerization of PPAR with RXR occurs, and the heterodimer binds to a specific cis-acting DNA response element termed the peroxisome proliferator response element (PPRE) and activates the various genes involved in the regulation of lipid metabolism. Phytanic acid, a phytol metabolite, is a ligand that activates retinoid X receptor (RXR)
(610), ß (6,8,11), and
(6,7), and peroxisome proliferator-activated receptor (PPAR)
(9,10,1215),
(9,14,15), and
(9,14,15). There is information (8) to suggest that another phytol metabolite, pristanic acid, also acts as an activator of PPAR and RXR. However, phytol itself is virtually ineffective in activating these nuclear receptors (6,7,15). Therefore, it is expected that after conversion into its metabolites, dietary phytol would activate the genes targeted by the PPAR-RXR heterodimer in animals. In fact, it was demonstrated that consumption of phytol increased the hepatic concentration of phytanic and pristanic acids in mice (16), and this was associated with an upregulation of the expression of PPAR/RXR-dependent genes including those for liver-type fatty acidbinding protein (12,13) and various enzymes involved in fatty acid oxidation (12,16).
Fat type is also crucial to lipid metabolism. Dietary fats rich in (n-3) fatty acids such as fish, linseed, and perilla oils (1721), and borage oil rich in
-linolenic acid (22,23) increase the activities and mRNA abundance of hepatic fatty acid oxidation enzymes. Here, PUFA or some of their metabolites (prostanoids) similar to phytol metabolites are considered natural ligands and hence activators of PPAR (2426) and RXR (2729). It is therefore possible that the simultaneous ingestion of phytol and PUFA affects hepatic fatty acid metabolism differently than the physiological activities of individual compounds through the intricate interaction of phytol metabolites and PUFA with nuclear receptors. With this understanding, we examined the interaction of phytol and different fats, either palm oil (a saturated fat) or fats rich in (n-6)(safflower oil) or (n-3) (fish oil) PUFA, in affecting hepatic fatty acid oxidation in mice in the present study.
| MATERIALS AND METHODS |
|---|
|
|
|---|
|
0.75 g of each liver was homogenized in 6.0 mL of a solution containing 0.25 mol/L sucrose, 1 mmol/L EDTA, and 3 mmol/L Tris-HCl (pH7.2). The activities of various enzymes involved in hepatic fatty acid oxidation were measured spectrophotometrically using the whole-liver homogenate stored at 40°C for up to 10 d as an enzyme source as detailed previously (17,18,20,21). Carnitine palmitoyltransferase activity was analyzed in the presence of detergent (triton X-100).
RNA analysis.
Hepatic RNA was extracted (31), and purified with an RNeasy Mini Kit (QIAGEN). mRNA abundance was analyzed by quantitative real-time PCR, as detailed previously (32). mRNA abundance was calculated as a ratio to the ß-actin mRNA abundance in each cDNA sample and expressed as a percentage, assigning a value of 100 for mice fed a phytol-free diet containing 100 g/kg palm oil. Nucleotide sequences for forward and reverse primers, and probes to detect mRNAs for various enzymes involved in hepatic fatty acid oxidation and peroxin 11
and cytochrome P450 IV A-1 were reported elsewhere (32). Nucleotide sequences for forward and reverse primers, and a probe to detect mRNA of phytanoyl-CoA hydroxylase were as follows: 5'-GATGGAAAAGGGCGATACTGTTT-3', 5'-TTGAGTTTTGTTCCGACCAGATC-3', and 5'-CTTCCACCCTCTGCTCATCCAT-3', respectively. Primers and probes supplied by Applied Biosystems (Assay on Demand ProductsTM) were used to measure mRNA abundance of ALDH3a2, 2-hydroxyphytanoyl-CoA lyase and sterol carrier protein-2 (SCP2).
Analysis of hepatic phytanic acid. Liver lipids were extracted and purified (33). The concentration of phytanic acid in the liver lipid extract was analyzed by GLC using a 1.4BDS capillary column (40 m x 0.25 mm, Shimadzu) and heneicosanoic acid as an internal standard. Phytanic acid methyl ester as a reference standard was purchased from Sigma-Aldrich.
Statistical analysis. StatView for Macintosh (SAS Institute) was used for statistical analyses. DAgostino-Pearsons test was used to inspect the constancy of the variance of the observations. If variances were heterogeneous, they were transformed logarithmically. The transformations were successful in rendering the variance of the observations constant, and hence the transformed values were used for subsequent statistical evaluations. The data for the 2-way classification were analyzed using a 2-way ANOVA. If no significant interaction existed, the Tukey-Kramer post-hoc test was conducted to detect differential effects of palm, safflower, and fish oils. When the interaction was significant, the data were reanalyzed with a 1-way ANOVA and the post-hoc test. The data for the one-way classification were analyzed using a 1-way ANOVA and the post-hoc test. Differences were considered significant when P < 0.05.
| RESULTS |
|---|
|
|
|---|
|
|
-oxidation of fatty acids, and a peroxisomal membrane protein (peroxin 11
) induced by peroxisome proliferators (Table 4). Values are expressed as percentages with mice fed a palm oil diet free of phytol assigned a value of 100. Among the groups of mice fed phytol-free diets, the mRNA abundance of hepatic peroxisomal and mitochondrial fatty acid oxidation enzymes and of peroxin 11
and cytochrome P-450 IV A1 was higher in mice fed fish oil than in those fed palm and safflower oils. When the dietary fat was palm oil, the mRNA abundance of enzymes involved in fatty acid oxidation, peroxin 11
, and cytochrome P-450 IV A1 for mice given the phytol-containing diet was 1.4- to 3.0-fold, 1.8-fold, and 10.3-fold, respectively, that of mice fed the phytol-free diet. However, increases were greatly attenuated in mice given safflower and fish oils, especially that latter as indicated by significant interactions between dietary fat type and phytol for all of the variables.
|
|
| DISCUSSION |
|---|
|
|
|---|
Great diversity is characteristic of the ß-oxidation pathway. Several enzyme species differing in substrate specificity located either in peroxisomes or in mitochondria are involved at each step of the ß-oxidation cycle. The fatty acid oxidation enzyme activity measured in cell-free enzyme preparations therefore represents the sum of the activity of various enzymes under the given conditions of the enzyme assay. There are at least 3 enzymes possessing carnitine palmitoyltransferase activity (carnitine palmitoyltransferase I and II, and carnitine octanoyltransferase). Carnitine palmitoyltransferase I is unstable when released from its membrane environment, and freezing-thawing of mitochondria and addition of detergent inactivate the enzyme (37). Therefore, the carnitine palmitoyltransferase activity measured in the present study using freeze-thawed total homogenate as an enzyme source and in the presence of detergent may represent the sum of the activities of carnitine palmitoyltransferase II and carnitine octanoyltransferase.
Studies showed that PUFA are the ligands and activators of PPAR (2426) and RXR (2729). Therefore, it is possible that the consumption of a large amount of PUFA interferes with the binding of phytanic acid, a metabolite of phytol, to these nuclear receptors and hence attenuates the dietary phytol-dependent increase in hepatic fatty acid oxidation despite the fact that the binding affinity for and hence the ability to activate PPAR (12,15) and RXR (11) are much lower with PUFA than with phytanic acid. On a related note, Lee and Hwang (38) reported that docosahexaenoic acid suppressed a PPAR agonistinduced transactivation of PPRE and DNA-binding of PPAR in colon tumor cells.
Alternatively, there is the possibility that polyunsaturated fats interfere with the phytol metabolism to produce active phytol metabolites responsible for inducing hepatic fatty acid oxidation and hence attenuate phytol-dependent changes in the metabolic activity. Unexpectedly, however, the hepatic phytanic acid concentration was much lower for mice fed phytol and palm oil in combination than for those fed phytol and safflower or fish oil in combination. Therefore, it is difficult to consider that alterations in the hepatic phytanic acid concentration are responsible for the dietary fatdependent changes in the activity of dietary phytol to upregulate hepatic fatty acid oxidation.
There is the possibility that alterations in the gene expression of proteins involved in phytol metabolism are responsible for dietary fatdependent changes in the hepatic phytanic acid concentration. There were no correlations between the abundance of mRNAs for ALDH3a2, phytanoyl-CoA hydroxylase, and 2-hydroxyphytanoyl-CoA lyase and the phytanic acid concentration in the liver of mice fed phytol-containing diets. However, we found that SCP2 mRNA abundance was inversely correlated with the phytanic acid concentration in the liver of mice fed phytol diets containing various fats. It was demonstrated that phytanic acid accumulated in the tissues of SCP2 null mice (34,39), indicating that this protein plays a crucial role in the degradation of phytanic acid. Therefore, changes in SCP2 mRNA expression may account for the dietary fat-dependent changes in the hepatic phytanic acid concentration.
In conclusion, we demonstrated that safflower oil rich in (n-6) fatty acids and fish oil rich in (n-3) fatty acids, especially the latter, compared with a saturated fat (palm oil), greatly attenuated the dietary phytol-dependent increase in the activities and mRNA abundance of enzymes involved in hepatic fatty acid oxidation in mice. We also showed that dietary fat type markedly modified the hepatic concentration of phytanic acid, a metabolite of phytol that is a potent activator of RXR (811) and of PPAR (9,10,1215). However, the changes in the hepatic phytanic acid concentration cannot account for the modification by dietary fat type of the physiological activity of dietary phytol to increase hepatic fatty acid oxidation.
| FOOTNOTES |
|---|
3 Abbreviations used: ALDH3a2, aldehyde dehydrogenase family 3 member A2; PPAR, peroxisome proliferator-activated receptor; PPRE, peroxisome proliferator response element; RXR, retinoid X receptor; SCP2, sterol carrier protein-2. ![]()
Manuscript received 25 September 2005. Initial review completed 7 November 2005. Revision accepted 20 January 2006.
| LITERATURE CITED |
|---|
|
|
|---|
1. Mukherji M, Schofield CJ, Wierzbicki AS, Jansen GA, Wanders RJ, Lloyd MD. The chemical biology of branched-chain lipid metabolism. Prog Lipid Res. 2003;42:35976.[Medline]
2. Wanders RJ, Jansen GA, Lloyd MD. Phytanic acid alpha-oxidation, new insights into an old problem: a review. Biochim Biophys Acta. 2003;1631:11935.[Medline]
3. van den Brink DM, van Miert JN, Dacremont G, Rontani JF, Wanders RJ. Characterization of the final step in the conversion of phytol into phytanic acid. J Biol Chem. 2005;280:2683844.
4. Schoonjans K, Staels B, Auwerx J. Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. J Lipid Res. 1996;37:90725.[Abstract]
5. Reddy JK, Hashimoto T. Peroxisomal ß-oxidation and peroxisome proliferator-activated receptor
: an adaptive metabolic system. Annu Rev Nutr. 2001;21:193230.[Medline]
6. Kitareewan S, Burka LT, Tomer KB, Parker CE, Deterding LJ, Stevens RD, Forman BM, Mais DE, Heyman RA, et al. Phytol metabolites are circulating dietary factors that activate the nuclear receptor RXR. Mol Biol Cell. 1996;7:115366.[Abstract]
7. Lemotte PK, Keidel S, Apfel CM. Phytanic acid is a retinoid X receptor ligand. Eur J Biochem. 1996;236:32833.[Medline]
8. Zomer AW, van der Burg B, Jansen GA, Wanders RJ, Poll-The BT, van der Saag PT. Pristanic acid and phytanic acid: naturally occurring ligands for the nuclear receptor peroxisome proliferator-activated receptor
. J Lipid Res. 2000;41:18017.
9. Schlüter A, Barberá MJ, Iglesias R, Giralt M, Villarroya F. Phytanic acid, a novel activator of uncoupling protein-1 gene transcription and brown adipocyte differentiation. Biochem J. 2002;362:619.[Medline]
10. Schlüter A, Giralt M, Iglesias R, Villarroya F. Phytanic acid, but not pristanic acid, mediates the positive effects of phytol derivatives on brown adipocyte differentiation. FEBS Lett. 2002;517:836.[Medline]
11. Radominska-Pandya A, Chen G. Photoaffinity labeling of human retinoid X receptor ß (RXRß) with 9-cis-retinoic acid: identification of phytanic acid, docosahexaenoic acid, and lithocholic acid as ligands for RXRß. Biochemistry. 2002;41:488390.[Medline]
12. Ellinghaus P, Wolfrum C, Assmann G, Spener F, Seedorf U. Phytanic acid activates the peroxisome proliferator-activated receptor
(PPAR
) in sterol carrier protein 2-/sterol carrier protein x-deficient mice. J Biol Chem. 1999;274:276672.
13. Wolfrum C, Ellinghaus P, Fobker M, Seedorf U, Assmann G, Borchers T, Spener F. Phytanic acid is ligand and transcriptional activator of murine liver fatty acid binding protein. J Lipid Res. 1999;40:70814.
14. Lampen A, Meyer S, Nau H. Phytanic acid and docosahexaenoic acid increase the metabolism of all-trans-retinoic acid and CYP26 gene expression in intestinal cells. Biochim Biophys Acta. 2001;1521:97106.[Medline]
15. Heim M, Johnson J, Boess F, Bendik I, Weber P, Hunziker W, Fluhmann B. Phytanic acid, a natural peroxisome proliferator-activated receptor (PPAR) agonist, regulates glucose metabolism in rat primary hepatocytes. FASEB J. 2002;16:71820.
16. Gloerich J, van Vlies N, Jansen GA, Denis S, Ruiter JP, van Werkhoven MA, Duran M, Vaz FM, Wanders RJ, Ferdinandusse S. A phytol-enriched diet induces changes in fatty acid metabolism in mice both via PPAR
-dependent and -independent pathways. J Lipid Res. 2005;46:71626.
17. Ide T, Murata M, Sugano M. Stimulation of the activities of hepatic fatty acid oxidation enzymes by dietary fat rich in
-linolenic acid in rats. J Lipid Res. 1996;37:44863.[Abstract]
18. Kabir Y, Ide T. Activity of hepatic fatty acid oxidation enzymes in rats fed
-linolenic acid. Biochim Biophys Acta. 1996;1304:10519.[Medline]
19. Ren B, Thelen AP, Petters JM, Gonzalez FJ, Jump DB. Polyunsaturated fatty acid suppression of hepatic fatty acid synthase and S14 gene expression does not require peroxisome proliferator-activated receptor
. J Biol Chem. 1997;272:2682732.
20. Ide T, Kobayashi H, Ashakumary L, Rouyer IA, Takahashi Y, Aoyama T, Hashimoto T, Mizugaki M. Comparative effects of perilla and fish oils on the activity and gene expression of fatty acid oxidation enzymes in rat liver. Biochim Biophys Acta. 2000;1485:2335.[Medline]
21. Ide T, Takahashi Y, Kushiro M, Tachibana M, Matsushima Y. Effect of n-3 fatty acids on serum lipid levels and hepatic fatty acid metabolism in BALB/c.KOR-Apoeshl mice deficient in apolipoprotein E expression. J Nutr Biochem. 2004;15:16978.[Medline]
22. Kumamoto T, Ide T. Comparative effects of
- and
-linolenic acids on rat liver fatty acid oxidation. Lipids. 1998;33:64754.[Medline]
23. Takahashi Y, Ide T, Fujita H. Dietary gamma-linolenic acid in the form of borage oil causes less body fat accumulation accompanying an increase in uncoupling protein 1 mRNA level in brown adipose tissue. Comp Biochem Physiol B. 2000;127:21322.[Medline]
24. Keller H, Dreyer C, Medin J, Mahfoudi A, Ozato K, Wahli W. Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers. Proc Natl Acad Sci U S A. 1993;90:216064.
25. Forman BM, Chen J, Evans RM. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors
and
. Proc Natl Acad Sci U S A. 1997;94:431217.
26. Kliewer SA, Sundseth SS, Jones SA, Brown PJ, Wisley GB, Koble CS, Devchand P, Wahli W, Willson TM, et al. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors
and
. Proc Natl Acad Sci U S A. 1997;94:431823.
27. De Urquiza AM, Liu S, Sjoberg M, Zetterstrom RH, Griffiths W, Sjovall J, Perlmann T. Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain. Science. 2000;290:21404.
28. Goldstein JT, Dobrzyn A, Clagett-Dame M, Pike JW, DeLuca HF. Isolation and characterization of unsaturated fatty acids as natural ligands for the retinoid-X receptor. Arch Biochem Biophys. 2003;420:18593.[Medline]
29. Lengqvist J, Mata De Urquiza A, Bergman AC, Wilson TM, Sjövall J, Perlmann T, Griffiths WJ. Polyunsaturated fatty acids including docosahexaenoic and arachidonic acid bind to the retinoid X receptor
ligand binding domain. Mol Cell Proteomics. 2004;3:692703.
30. American Institute of NutritionReport of the American Institute of Nurtition ad hoc committee on standards for nutritional studies. J Nutr. 1977;107:13408.
31. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:1569.[Medline]
32. Ide T. Interaction of fish oil and conjugated linoleic acid in affecting hepatic activity of lipogenic enzymes and gene expression in liver and adipose tissue. Diabetes. 2005;54:41223.
33. Folch J, Lees M, Sloane-Stanley GH. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem. 1957;226:497509.
34. Seedorf U, Ellinghaus P, Roch Nofer J. Sterol carrier protein-2. Biochim Biophys Acta. 2000;1486:4554.[Medline]
35. Yanagita T, Satoh M, Nomura H, Enomoto N, Sugano M. Alteration of hepatic phospholipids in rats and mice by feeding di-(2-ethylhexyl)adipate and di-(2-ethylhexyl)phthalate. Lipids. 1987;22:5727.[Medline]
36. Ashakumary L, Rouyer I, Takahashi Y, Ide T, Fukuda N, Aoyama T, Hashimoto T, Mizugaki M, Sugano M. Sesamin, a sesame lignan, is a potent inducer of hepatic fatty acid oxidation in the rat. Metabolism. 1999;48:130313.[Medline]
37. McGarry JD. Travels with carnitine palmitoyltransferase I: from liver to germ cell with stops in between. Biochem Soc Trans. 2001;29:2415.[Medline]
38. Lee JY, Hwang DH. Docosahexaenoic acid suppresses the activity of peroxisome proliferator-activated receptors in a colon tumor cell line. Biochem Biophys Res Commun. 2002;298:66774.[Medline]
39. Seedorf U, Raabe M, Ellinghaus P, Kannenberg F, Fobker M, Engel T, Denis S, Wouters F, Wirtz KW, et al. Defective peroxisomal catabolism of branched fatty acyl coenzyme A in mice lacking the sterol carrier protein-2/sterol carrier protein-x gene function. Genes Dev. 1998;12:1189201.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||